Received: from LO0P265CA0014.GBRP265.PROD.OUTLOOK.COM (2603:10a6:600:355::16) by AM7PR02MB6467.eurprd02.prod.outlook.com (2603:10a6:20b:1b1::15) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.569.9; Thu, 29 Oct 2026 09:39:35 +0000 Received: from MI3PEPF00008559.eurprd05.prod.outlook.com (2603:10a6:600:355:cafe::a) by LO0P265CA0014.outlook.office365.com (2603:10a6:600:355::16) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.546.22 via Frontend Transport; Thu, 29 Oct 2026 09:39:34 +0000 Received: from westeu11-emailsignatures-cloud.codetwo.com (20.93.157.195) by MI3PEPF00008559.mail.protection.outlook.com (10.167.240.21) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.569.4 via Frontend Transport; Thu, 29 Oct 2026 09:39:34 +0000 Received: from AM7PR02MB6467.eurprd02.prod.outlook.com (2603:10a6:20b:1b1::15) by VI1PR02MB5024.eurprd02.prod.outlook.com with HTTPS; Thu, 29 Oct 2026 09:39:37 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104]) by GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104%5]) with mapi id 15.21.0569.007; Thu, 29 Oct 2026 09:39:28 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com (2603:10a6:150:351::5) by GVXPR02MB8302.eurprd02.prod.outlook.com (2603:10a6:150:6c::8) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.546.22; Thu, 29 Oct 2026 09:39:28 +0000 Received: from DB3PR08CU002.outbound.protection.outlook.com (40.93.64.81) by westeu11-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Thu, 29 Oct 2026 09:39:33 +0000 From: "Kommunikatsioon - RA" To: =?iso-8859-1?Q?K=E4rolin_Jenas_-_RA?= References: In-Reply-To: Subject: =?iso-8859-1?Q?Ed:_KIIRE!_=D5htuleht_-_gripivaktsiinide_k=E4ttesaadavus?= Date: Thu, 29 Oct 2026 11:39:28 +0200 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_05B8_01DD7033.5F4DCC40" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQJ5RbnDVPefuq9mZF5ZLgLTSjzt7AIl7edu Authentication-Results: mx.microsoft.com 1; spf=pass (sender IP is 20.93.157.195) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 29 Oct 2026 09:39:34.5911 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 623dd0a4-8419-438c-440c-08df35a08a94 X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GV2PR02MB11921:EE_|GVXPR02MB8302:EE_|MI3PEPF00008559:EE_|AM7PR02MB6467:EE_|VI1PR02MB5024:EE_ X-MS-Exchange-Organization-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: 623dd0a4-8419-438c-440c-08df35a08a94 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|35042699022|23010399003|31052699007|39142699007|366016|82310400026|11063799006|56012099006|261009223027099003|261026140227099003|261028144727099003|261022105027099003|261022075727099003|261021123027099003|10067099003|55112099003|18002099003|22082099003|8096899003|41050700001; X-Forefront-Antispam-Report: CIP:20.93.157.195;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu11-emailsignatures-cloud.codetwo.com;PTR:westeu11-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(35042699022)(23010399003)(31052699007)(39142699007)(366016)(82310400026)(11063799006)(56012099006)(261009223027099003)(261026140227099003)(261028144727099003)(261022105027099003)(261022075727099003)(261021123027099003)(10067099003)(55112099003)(18002099003)(22082099003)(8096899003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 29 Oct 2026 09:39:34.5386 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 623dd0a4-8419-438c-440c-08df35a08a94 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: GVXPR02MB8302 X-MS-Exchange-Transport-CrossTenantHeadersStamped: AM7PR02MB6467 X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.8521083 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0569.002 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009284)(140003); X-Microsoft-Antispam-Message-Info: 6qKc3mfLTqsX79WKBi611qflGRRED3HkGpfX7NywMCGzqvlCHpLmVbQyjhYboKxiLl2vNfHu1FT6+OOqBaxdNqfZUBhRpS9+j3nxw2Csk3Z5H997+w/fyNaWeA0VQxE3S8CWipZ7LOGtCJaVlyztoMjpvk0PriQ46xlCD8M/C6N0Lrh24cqIcvYQkwTX0SG7iff5j7NHzHgdXnpoV10W3aNsTqyau9o0qZPidIyWXcXsIQcBBwvTTdnPSCh2EXGByDG/nT8FdqIXN8gYbwO5S603lHSdCdAuS6GyKPrrMCuN0eTAd4BrUME6VqyxR49z0Tp9RalIcp9LwtEeTmDmmvb12IhQTJgFJEymplM2XoxsPMej4jYm8D0hqo8QaYiYXCMNZ+OvWl1sKn0Es11b6cjTpsY/bp3nzFefMoDP0tc9gfUYJrGWMdT7/5Bpm7yyQQXV3ckCzybnxUbSPyksN28ADllcvGZ5g5i99SHP8HPykcPCsslC+H/mp/WbHWSkJ0K++4oK1TxVCRoSFzOK62Esle5A1YUGi9ofkP4aPwI21BQsbgOmhRJtx687MdC3/pmaXYcUTCb2wZ7pUr/qtI82pqdXFdDX1OO2IuSzYGU9DgwN+Z2KaY9s2QDjMLyHZgld04nxGyE1uSMzSTHCz6Me3UIi8JYScjCBWQFYziSd6Sy1ai+XMqQri517oiARmvpXwrJGWil8R3zhV9k1YR35WAcrYG/SGmuYz+MlbyuPVlwYlMCVpc5gmwhBHsxhIz8kBJ36Vr6qflpbW+bnB3LU5PMbrNy2Ymz0KkqZaGGCJQmkyMJ+aq5AYSiIPeJQcv1EqAKXZhr1+SRH7bKsuZFPqBBxbAGT93DT73z1X4vYT0xPTgeJRTsbUR5B8hMeNYIJcuyBEGeDfPLxqBTkkA== Content-Language: et x-ms-exchange-organization-originalclientipaddress: 146.255.182.120 x-ms-exchange-organization-originalserveripaddress: 10.167.240.21 received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 20.93.157.195 as permitted sender) receiver=protection.outlook.com; client-ip=20.93.157.195; helo=westeu11-emailsignatures-cloud.codetwo.com; pr=C X-OlkEid: 00000000354180B9476080459B05E1BF834B446F070034AD76187591974DBF6C4F76951C873A01000200000000002495DA25D80D98438130990BFAFE78050000000011CA0000A514936091BC2041B2A913A9592BCFF4 X-MS-Has-Attach: X-MS-TNEF-Correlator: X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|39142699007|23010399003|31052699007|366016|261028144727099003|261022075727099003|261026140227099003|11063799006|56012099006|261022105027099003|261021123027099003|261009223027099003|10067099003|18002099003|22082099003|8096899003|55112099003|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV2PR02MB11921.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(39142699007)(23010399003)(31052699007)(366016)(261028144727099003)(261022075727099003)(261026140227099003)(11063799006)(56012099006)(261022105027099003)(261021123027099003)(261009223027099003)(10067099003)(18002099003)(22082099003)(8096899003)(55112099003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: 2Jc618K6R1fkbw6bmj7H4kYKffaab6pFiE+gVoiQLYM27fquyXBFsfH6QtdXNa3eAJII4CPvKoca/3mPJFCXwDA+XifoEILH9hXDujSuGHTVkA6+LAUZ73m2efX9SFCW55bmcBN5Wplsv9P0BwJKgoJD0LoYXOf5efP5hzgv49UiP4VKnDLlpbGxzuQAt9NaOd+4iH/r1T1siLK/Xr+yxjl85u8lrN7cFvf6ySfqowrdc/DFW0qVh3KfFswjn00GwY9396+QdAu4Jb0CI28mQwDUL4uf1zapcw1qXLc4J0iqIfEcuP3bflbYnvr6sCL/QD+UosLN+D1me3ZnNEbEUA== X-OrganizationHeadersPreserved: GVXPR02MB8302.eurprd02.prod.outlook.com X-CodeTwo-MessageID: 5d9c7c0f-6e29-4c98-9388-28abb36a6022.20261029093933@westeu11-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-CrossPremisesHeadersPromoted: MI3PEPF00008559.eurprd05.prod.outlook.com X-CrossPremisesHeadersFiltered: MI3PEPF00008559.eurprd05.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: MI3PEPF00008559.eurprd05.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Office365-Filtering-Correlation-Id-Prvs: 2a5baf44-bc43-4101-4fd1-08df35a086b3 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[20.93.157.195];Helo=[westeu11-emailsignatures-cloud.codetwo.com] acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-10-29T09:39:27.507Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; authentication-results-original: mx.microsoft.com 1; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; This is a multipart message in MIME format. ------=_NextPart_000_05B8_01DD7033.5F4DCC40 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 8bit _____ Saatja: Joonas Marten Abram Saadetud: neljapäev, 29. oktoober 2026 09:45 Adressaat: Kommunikatsioon - RA ; Kristi Sarap - RA ; Carmen Katariina Sikk - RA Teema: KIIRE! Õhtuleht - gripivaktsiinide kättesaadavus Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Kirjutan Teile Õhtulehe uudistest. Soovin teha lühikese uudisloo gripivaktsiinide kättesaadavusest tänavusel hooajal. Ravimiameti 23. septembril avaldatud info järgi pidi esimene tarne jõudma Eestisse oktoobri lõpus. Palun täpsustage: * Kas esimene tarne on Eestisse saabunud? Kui palju vaktsiiniannuseid on tegelikult kohale jõudnud? * Millal algab riskirühmade tasuta vaktsineerimine ning millal saavad inimesed vaktsineerimisele aegu broneerida? * Kas praeguse prognoosi järgi jätkub 233 000 vaktsiiniannusest kõigile soovijatele? Kas on oodata kättesaadavusprobleeme? * Kas novembri keskpaiga ja jaanuari tarnete ajakava on endiselt kehtiv? * Kas riskirühmadele mõeldud 93 000 annust on eraldi reserveeritud ning kuidas tagatakse nende kättesaadavus? Võimalusel palun ka värsket infot tasuliste Efluelda ja Fluenz vaktsiinide saadavuse kohta. Ette tänades vastuste eest! Joonas Marten Abram Õhtulehe uudistereporter ------=_NextPart_000_05B8_01DD7033.5F4DCC40 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable

Saatja: Joonas Marten = Abram <joonas.marten.abram@ohtuleht.ee>
Saadetud: neljap=E4ev, 29. oktoober 2026 09:45
Adressaat: Kommunikatsioon - RA <press@ravimiamet.ee>; = Kristi Sarap - RA <kristi.sarap@ravimiamet.ee>; Carmen Katariina = Sikk - RA <carmen.katariina.sikk@ravimiamet.ee>
Teema: KIIRE! =D5htuleht - gripivaktsiinide = k=E4ttesaadavus
 

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tere!
Kirjutan Teile =D5htulehe uudistest. Soovin teha l=FChikese uudisloo = gripivaktsiinide k=E4ttesaadavusest t=E4navusel hooajal. Ravimiameti 23. = septembril avaldatud info j=E4rgi pidi esimene tarne j=F5udma Eestisse = oktoobri l=F5pus.
Palun t=E4psustage:
  • Kas esimene tarne on Eestisse saabunud? Kui palju vaktsiiniannuseid on = tegelikult kohale j=F5udnud?
  • Millal algab riskir=FChmade tasuta vaktsineerimine ning millal saavad = inimesed vaktsineerimisele aegu broneerida?
  • Kas praeguse prognoosi j=E4rgi j=E4tkub 233 000 vaktsiiniannusest = k=F5igile soovijatele? Kas on oodata k=E4ttesaadavusprobleeme?
  • Kas novembri keskpaiga ja jaanuari tarnete ajakava on endiselt = kehtiv?
  • Kas riskir=FChmadele m=F5eldud 93 000 annust on eraldi reserveeritud = ning kuidas tagatakse nende k=E4ttesaadavus?
V=F5imalusel palun ka v=E4rsket infot tasuliste Efluelda ja Fluenz = vaktsiinide saadavuse kohta.

Ette t=E4nades vastuste eest!
Joonas Marten Abram
=D5htulehe uudistereporter

------=_NextPart_000_05B8_01DD7033.5F4DCC40--